Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Δευτέρα 23 Μαΐου 2016

Hearing Aid Selection and Fitting Tips Gleaned from Recent Research

The first thing I would like to talk about is the Acceptable Noise Level (ANL) test that was developed at the University of Tennessee, based on the research of Anna Nabelek dating back to 1991. For those of you who are not familiar with this test, here is a quick review of how it works: The test usually is conducted bilaterally in the sound field, not under earphones. You first determine the patient's most comfortable listening level (MCL) for continuous discourse. The standard material is a travelogue about Arizona. It's a loudness task, not a speech recognition task, so the actual speech material doesn't matter too much. 1XLZfZY

from #Audiology via xlomafota13 on Inoreader http://ift.tt/1OIhEzj
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TEowDw
via IFTTT



from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TpVp8K
via IFTTT

Hearing Aid Directionality with Binaural Processing

The fact that two ears are better than one is well-established. The human auditory system integrates information from both ears providing benefits in terms of loudness, localization, sound quality, noise suppression, speech clarity and listening in noise. The ability to selectively attend to particular sounds, like a single voice among many talkers, is one of the most amazing and significant benefits of binaural hearing. 1XLZ80h

from #Audiology via ola Kala on Inoreader http://ift.tt/1OIhsAd
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/20pqvMv
via IFTTT



from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1YQKDH8
via IFTTT

The Early Days of PEG and PEGylation (1970s-1990s)

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Allan S. Hoffman
The idea to conjugate PEG [poly(ethylene glycol)] to a protein, i.e., to "PEGylate" a protein, was first proposed by Prof. Frank Davis (Rutgers Univ.) in the late 1960s. He wanted to make the new recombinant proteins less immunogenic in our bodies, and thereby enhance their circulation and activity lifetimes. He thought that if he could conjugate a hydrophilic polymer to the "new" protein, it might not be recognized by the immune system as a foreign molecule. This article is a contribution to the Zwitterionic Special Issue as a personal commentary tracing the story of PEGylation from its beginning with Dr. Davis through a currentday post-script.Statement of significantThe author knows (or knew) personally most of the early workers in the fields of PEG, PEGylation and non-fouling surfaces, and he has also been personally active in the field since its early days.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDWa0F
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1qE0JrH
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TpVCc0
via IFTTT

Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Clara González-Chomón, Maite Silva, Angel Concheiro, Carmen Alvarez-Lorenzo
Combination of the ability of contact lenses (CLs) to act as a physical barrier against airborne antigen and to serve as a sustained depot of antihistaminic drugs may improve the efficiency of treatments of some ocular allergic diseases. The aim of this work was to develop CLs that exhibit affinity to olopatadine by mimicking the composition of the natural H1-receptor for which olopatadine behaves as a selective antagonist. Functional monomers that match the chemical groups of the receptor and application of the molecular imprinting technology led to hydrogels able to load high amounts of olopatadine and to sustain the release once in contact with lachrymal fluid. Optimized hydrogels prepared with acrylic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid and benzylmethacrylate as functional monomers provided in few hours olopatadine concentrations similar to those of commercially available eye drops but the levels could be sustained for a whole day, demonstrating their efficacy. Olopatadine-loaded CLs successfully passed the HET-CAM test of ocular irritancy and showed good compatibility with mast cells. They were able to inhibit the release of histamine and TNF-α from sensitized mast cells, proving their potential application in preventing and treating allergic conjunctivitis.Statement of significanceContact lenses (CLs) with affinity for antiallergic drugs may constitute an advantageous alternative to eye drops in management of ocular allergies for both contact lens wearers and patients who eventually use neutral CLs as therapeutic platforms. The present work represents a step forward in the state of the art of drug-CL combo products by (i) mimicking the composition of the human receptor of the drug, (ii) exploring combinations of functional monomers that include a monomer (2-acrylamido-2-methyl-1-propanesulfonic acid; AMPSA) with a strong acid group (pKa <4) able to enhance the interaction of the network with olopatadine in the saline environment of the lachrymal fluid, and (ii) analysing in detail the antihistamic effects provided by olopatadine released from the CLs on sensitized mast cells.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDVZlZ
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1WJWs3U
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1YQKsvb
via IFTTT

Development of a new family of monolithic calcium (pyro)phosphate glasses by soft chemistry

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Jérémy Soulié, Pierre Gras, Olivier Marsan, Danielle Laurencin, Christian Rey, Christèle Combes
The development of bioactive phosphate-based glasses is essential in biomaterials science, and especially for bone substitution applications. In this context, the preparation of amorphous calcium-phosphorus hydroxide/oxide monoliths at low temperature is a key challenge for being able to develop novel hybrid materials for these applications. We herein report for the first time the synthesis and physical chemical characterisation of a novel family of pyrophosphate-based glasses (with the formula: {[(Ca2+)1-x(H+/K+)2x]2[(P2O74-)1-y(PO43-)4y/3]} n(H2O)), which were prepared by soft chemistry using low temperatures (T < 70°C) and water as a solvent. The effect of the initial Ca/Pyrophosphate ratio on the structure and morphology of these pyrophosphate glasses was investigated in detail. Depending on this ratio, a glass (mixed calcium pyro- and orthophosphate) or a glass-ceramic (Ca10K4(P2O7)6·9H2O crystals embedded in the amorphous phase) was obtained. The proportion of the crystalline phase increased with an increase in the Ca/Pyrophosphate ratio in the batch solution. As expected for a glass, the formation of the glassy material was demonstrated not to be thermodynamically but rather kinetically driven, and the washing step was found to be crucial to prevent crystallisation. The stability of the amorphous phase was discussed considering the structural degrees of freedom of pyrophosphate entities, ionic strength of the initial solution and the inhibitory effect of orthophosphate ions. Overall, this new strategy of preparation of monolithic calcium-(pyro)phosphate based glasses using soft chemistry in water is highly promising in view of preparing new functional organic-inorganic hybrids for bone substitution applications.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDWts8
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1WJWicM
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TpVhWZ
via IFTTT

Fatigue behaviors of HP-Mg, Mg-Ca and Mg-Zn-Ca biodegradable metals in air and simulated body fluid

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Dong Bian, Weirui Zhou, Yang Liu, Nan Li, Yufeng Zheng, Zhili Sun
The dynamic loading in human body, along with the corrosive body fluid, presents a great challenge for the practical use of biodegradable magnesium implants. In this study, a high purity magnesium (99.99 wt.%) and two typical promising biodegradable magnesium alloys (binary Mg-1Ca and ternary Mg-2Zn-0.2Ca) were chosen as the experimental materials. Their dynamic mechanical performances were comparatively evaluated by carrying out fatigue tests in air and in simulated body fluid (SBF). The fatigue strengths of HP-Mg, Mg-1Ca and Mg-2Zn-0.2Ca were all around 90 MPa in air, however, they decreased to 52 MPa, 70 MPa and 68 MPa in SBF at 4×106 cycles, respectively. The fatigue cracks initiated from the microstructural defects when tested in air, but nucleated from surface corrosion pits when tested in SBF. Cyclic loading significantly increased the corrosion rates of all the experimental materials compared to that in static SBF. Moreover, based on our findings, the fatigue failure processes and interactions between material, corrosion and cyclic loading were systematically discussed.Statement of SignificanceFatigue strength and life are vital parameters to the design of metallic implant devices. For the corrosion fatigue of biomedical magnesium alloys, we reported the corrosion fatigue behavior of AZ91D and WE43 in SBF (Acta Biomaterialia, 6 (2010) 4605-4613), and till now there is no other reports to our knowledge. We spent 3 years to finish the fatigue testing and get S-N curves for three more magnesium biomaterials, and our significant finding is that the fatigue strengths of HP-Mg, Mg-1Ca and Mg-2Zn-0.2Ca are all around 90 MPa in air but 52 MPa, 70 MPa and 68 MPa in SBF at 4×106 cycles, which will provide the first-hand data for the future magnesium implants design.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDW6xQ
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1qE0NaY
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1sxnVcy
via IFTTT

Bleak allergy

Dear Editor,
The prevalence of fish allergy in the general population is 0.1%–3%.1 Bleak (Alburnus alburnus) is a river fish belonging to the Cyprinidae family ( Fig. 1).2 Different fish-related panallergens have been described. 13 and 4 We report the first case of allergy to bleak where a panallergen was the sole trigger.
Bleak (Alburnus alburnus) of 15 cm in length.
Fig. 1. 
Bleak (Alburnus alburnus) of 15 cm in length.
We present the case of a 69-year-old non-atopic woman who suffered from edema of the tongue, uvular edema, generalized pruritic erythema and rapidly progressive dyspnea immediately after eating one piece of fried bleak. No other family member who ate the same fish had similar symptoms. One month before, she presented generalized urticaria after eating this fish previously well tolerated. Currently, she completely avoids fish and seafood. An allergy work-up was performed.
Skin-prick-prick (SPP) tests were positive (papule ≥3 mm than negative control) to river (bleak, pike, barbel, carp, trout) and sea (hake, cod, sardine, salmon) fish; and negative to anchovy, white tuna and red tuna. Skin-prick-tests (SPT) with negative (50% glycerinated saline) and positive (histamine, 10 mg/mL) controls were performed (BIAL-Arístegui, Bilbao, Spain). SPT was positive to extracts of bleak (body and head), carp, barbel, pike, hake, cod, sardine and salmon; and negative to sole, anchovy, tuna, clam, oyster, squid, prawn and Anisakis simplex. Protein extracts from pike, barbel and carp (bodies), and bleak (body and head) were prepared by homogenization in phosphate-buffered-saline, dialyzation and lyophilization.
Serum total IgE, specific IgE and baseline tryptase levels were measured by ImmunoCAP™ (ThermoFisher, Massachusetts, USA). Serum specific IgE levels against bleak body and head were measured with the enzyme allergosorbent technique (Specific IgE EIA kit, HYTEC, HYCOR Biomedical Ltd., USA). Two parvalbumin-dependent anaphylaxis patients served as positive blotting-assay controls (patient #1: serum specific IgE against Gad c 1 of 1.08 kUA/L; patient #2 of 38.40 kUA/L) (negative <0.35 kUA/L). Serum total IgE was 153 UI/mL (normal <100). Specific IgE against A. simplex was negative (<0.10 kUA/L) and positive to cod (1.34 kUA/L) and salmon (0.70 kUA/L). In contrast, specific IgE against different fish (trout, tilapia, grayling, bullhead, zander, sardine, anchovy, hake, tuna) and seafood (shrimp, mussel, squid) were negative (between 0.14 and 0.04 kUA/L) as well as against the parvalbumins Gad c 1 (0.06 kUA/L) and Cyp c 1 (0.12 kUA/L) and tropomyosinDer p 10 (<0.10 kUA/L). Serum baseline tryptase levels were of 3.6 and 4.1 μg/L (normal <11.4). Specific IgE levels to body and head bleak extracts were <0.35 kUA/L but higher than the value obtained with a control serum (pool of sera from non-atopic subjects), so both values were between 0.35 and 0 kUA/L.
Therefore, to ascertain whether bleak was the real cause of this anaphylactic reaction, bleak extracts (body and head) were studied by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions (2-mercaptoethanol),5 transferred onto polyvinylidene difluoride membrane filters (Millipore Corp., Bedford, Massachusetts, USA), and incubated with patient serum. Two IgE-binding bands of 55 kDa and less than 14 kDa were revealed in both bleak extracts (results not shown). An IgE-Immunoblotting assay after tricine-SDS-PAGE analysis with bleak body extract was performed as previously described.6 The membrane was incubated with patient serum and with a rabbit anti-serum against sardine parvalbumin. The same IgE-binding band profile was revealed with both sera. This result led us to suppose that all the IgE-binding bands detected were different aggregation states of the bleak parvalbumin, and the 11 kDa-IgE-binding band was the monomeric state of this protein (Fig. 2-I). Furthermore, the extracts of various river fish (pike, carp and barbel) were studied by the SDS-PAGE Immunoblotting method as described by Laemnli using patient serum and the sera from the two parvalbumin-allergic patients.5 The IgE-binding band profile was the same with the three sera, and the parvalbumin protein appeared as a protein with a molecular mass smaller than 14 kDa. The other higher bands observed are the different aggregation states of the parvalbumin as was detected by tricine-SDS-PAGE IgE-Immunoblotting (Fig. 2-I). SDS-PAGE Immunoblotting inhibition assays using extracts from pike, carp and barbel body (solid phases) showed that both bleak extracts (body and head) as well as carp, pike and barbel bodies were able to produce a total IgE binding inhibition on proteins from pike, carp and barbel extracts (Fig. 2-II). Finally, in order to confirm a clinical monosensitivity to bleak and/or to offer a safe alternative fish diet, we performed an oral food challenge (OFC) with canned tuna (negative specific IgE, SPT and SPP), raw red tuna (negative SPP) and anchovy (negative specific IgE, SPT and SPP) in a very cautious way as previously described.7 and 8 Our patient tolerated canned tuna and raw red tuna (both fish with no detected parvalbumin/g of fish),1but not anchovy. Subsequently, no OFC with other fish was performed. She also tolerated squid, shrimp and mussel.
I) SDS-PAGE Immunoblotting. A) Extract from raw bleak body; B) Extract from raw ...
Fig. 2. 
I) SDS-PAGE Immunoblotting. A) Extract from raw bleak body; B) Extract from raw barbel body. Lane P1, patient's serum; lane C, control serum (pool of sera from non-atopic subjects); lane S, rabbit anti-serum against sardine parvalbumin; lane C1, unimmunized rabbit serum; lane M, molecular mass marker; lane P2and P3, sera from control parvalbumin-allergic patients. II) SDS-PAGE Immunoblotting-inhibition showing the obtained results with barbel body extract as solid phase; the results were similar with pike and carp as solid phase. Solid phase: Extract from raw barbel body. Lane C, control serum (pool of sera from non-atopic subjects); lanes 1–6, patient's serum pre-incubated with raw barbel body extract (1), raw bleak body extract (2), raw bleak head extract (3), raw pike body extract (4), raw carp body extract (5), and lamb extract (6); lane M, molecular mass marker.
Spain is the country with the third highest fish consumption after Japan and Portugal.9Currently, part of the Spanish population consumes river non-marketed fish perhaps with the intention of avoiding Anisakis-parasited fish, but overlooking the risk of coming into contact with other allergenic fish proteins. Fish parvalbumins are proteins of 9–11 kDa which show a high degree of IgE cross-reactivity between them, including parvalbumin from river fish. 1,3 and 4 We highlight the negative specific IgE values detected in our patient's serum against the commercially available parvalbumins, Gad c 1 and Cyp c 1 (parvalbumin from a river fish) (ImmunoCAP system). Thus, our patient could have been diagnosed with an allergy exclusive to bleak and a life-threatening episode after eating other fish could have occurred.
In conclusion, as far as we know, this is the first published case of allergy to bleak. The parvalbumin proved to be the allergen even though a negative specific IgE value to parvalbumins was detected by means of conventional analyses, which are used for diagnosing parvalbumin-induced fish allergies. In this case, the clinical significance of the allergenic cross-reactivity between bleak parvalbumin and parvalbumin from river and sea fish was demonstrated by serologic tests and OFC.

Conflicts of interest

BB is an employee of BIAL-Arístegui. The rest of the authors have no conflict of interest.

Acknowledgments

This work was partially supported by a grant from Comunidad de Madrid MITIC-CM(S2010/BMD-2502). The work did not receive any grant, honorary, fees from BIAL-Arístegui, the employer of the author BB.

References

    • 2
    • U.S. Fish and Wildlife Service. Beak (Alburnus alburnus), Ecological Risk Screening Summary. Web Version of July 21, 2014. Available at http://ift.tt/27PYZgW.
    • 3
    • A. Kuehn, I. Swoboda, K. Arumugam, C. Hilger, F. Hentges
    • Fish allergens at a glance: variable allergenicity of parvalbumins, the major fish allergens
    • Front Immunol, 5 (2014), p. 179
    • 7
    • N. Yanagida, Y. Okada, S. Sato, M. Ebisawa
    • New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapies
    • Allergol Int, 65 (2016), pp. 135–140
    •  |   | 
    • 8
    • S. Vázquez-Cortés, B. Nuñez-Acevedo, L. Jimeno-Nogales, A. Ledesma, M. Fernández-Rivas
    • Selective allergy to the Salmonidae fish family: a selective parvalbumin epitope?
    • Ann Allergy Asthma Immunol, 109 (2012), pp. 362–363
    •  |   | 
    • 9
    • M. Perez-Gordo, J. Cuesta-Herranz, A.S. Maroto, B. Cases, M.D. Ibáñez, F. Vivanco, et al.
    • Identification of sole parvalbumin as a major allergen: study of cross-reactivity between parvalbumins in a Spanish fish-allergic population
    • Clin Exp Allergy, 41 (2011), pp. 750–758
    •  |   | 
Peer review under responsibility of Japanese Society of Allergology.
Corresponding author. Servicio de Enfermedades del Sistema Inmune–Alergia, Hospital Universitario Príncipe de Asturias, Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá, Carretera Madrid-Barcelona Km 33.600, Alcalá de Henares, Madrid, Spain.
Source:Allergology International
Author(s): José Barbarroja-Escudero, María-José Sánchez-González, Mercedes Rodríguez-Rodríguez, Darío Antolín-Amérigo, Borja Bartolomé, Melchor Alvarez-Mon


from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/27PZ83O
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1WK36qS
via IFTTT

Small B-cell lymphoid neoplasms involving the bone marrow and peripheral blood Report on the Bone Marrow

Issues in diagnosis of small B-cell lymphoid neoplasms involving the bone marrow and peripheral blood Report on the Bone Marrow workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology:

Abstract

Small B-cell lymphoid neoplasms are the most common lymphoproliferative disorders involving peripheral blood (PB) and bone marrow (BM). The Bone Marrow Workshop (BMW) organized by the European Bone Marrow Working Group (EBMWG) of the European Association for Haematopathology (EAHP) during the 17th EAHP Meeting in Istanbul October 2014 was dedicated to discussion of cases illustrating how the recent advances in immunophenotyping, molecular techniques and cytogenetics provide better understanding and classification of these entities. Submitted cases were grouped into following categories:
cases illustrating diagnostic difficulties in chronic lymphocytic leukaemia (CLL).
cases of BM manifestations of small B-cell lymphoid neoplasms other than CLL.
transformation of small B-cell lymphoid neoplasms in the BM.
multiclonality and composite lymphomas in the BM.
This report summarizes presented cases and conclusions of the BMW and provides practical recommendations for classification of the BM manifestations of small B-cell lymphoid neoplasms based on the current state of knowledge.
This article is protected by copyright. All rights reserved.


from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TtIlKa
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1OIh3xJ
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TtLj1k
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1sxotz1
via IFTTT

Comparison of the combination of dexmedetomidine and ketamine to propofol or propofol/sevoflurane for drug-induced sleep endoscopy in children

Summary

Aim

Examination of dynamic airway collapse in patients with obstructive sleep apnea (OSA) during drug-induced sleep endoscopy (DISE) can help identify the anatomic causes of airway obstruction. We hypothesized that a combination of dexmedetomidine and ketamine (Group DK) would result in fewer oxygen desaturations and a higher successful completion rate during DISE in children with OSA when compared to propofol (Group P) or sevoflurane/propofol (Group SP).

Methods

In this retrospective study, we reviewed the records of 59 children who presented for DISE between October 2013 and March 2015. Data analyzed included demographics, OSA severity, and hemodynamics (heart rate and blood pressure). The primary outcomes were airway desaturation during DISE to <85% and successful completion of DISE; these were compared between the three groups: DK, P, and SP.

Results

Preoperative polysomnography was available for 49 patients. There were significantly more patients with severe OSA in Group P as compared to the other two groups. The mean (±sd) bolus dose for ketamine, dexmedetomidine, and propofol were 2.0 ± 0.6 mg·kg−1, 1.9 ± 0.9 mcg·kg−1, and 1.8 ± 1.1 mg·kg−1, respectively. The mean (±sd) infusion rate for dexmedetomidine was 1.6 ± 0.7 mcg·kg−1·h−1 and for propofol was 248 ± 68 mcg·kg−1·min−1 in Group P and 192 ± 48 mcg·kg−1·min−1 in Group SP. Patients in Group DK had significantly fewer desaturations to <85% during DISE compared to Group P. Patients in Group DK had significantly more successful completion of DISE (100% Group DK, 92% Group P, and 79% Group SP) as compared to Group SP.

Conclusions

These results suggest that the described dose regimen of propofol used alone or in combination with sevoflurane appears to be associated with more oxygen desaturations and a lower rate of successful completion than a combination of dexmedetomidine and ketamine during DISE in children with OSA.

Thumbnail image of graphical abstract

from Anaesthesiology via xlomafota13 on Inoreader http://ift.tt/1s43ALM

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/20prhcu
via IFTTT

Hearing Aid Selection and Fitting Tips Gleaned from Recent Research

The first thing I would like to talk about is the Acceptable Noise Level (ANL) test that was developed at the University of Tennessee, based on the research of Anna Nabelek dating back to 1991. For those of you who are not familiar with this test, here is a quick review of how it works: The test usually is conducted bilaterally in the sound field, not under earphones. You first determine the patient's most comfortable listening level (MCL) for continuous discourse. The standard material is a travelogue about Arizona. It's a loudness task, not a speech recognition task, so the actual speech material doesn't matter too much.

from #Audiology via ola Kala on Inoreader http://ift.tt/1OIhEzj
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TEoFXu
via IFTTT

Hearing Aid Selection and Fitting Tips Gleaned from Recent Research

The first thing I would like to talk about is the Acceptable Noise Level (ANL) test that was developed at the University of Tennessee, based on the research of Anna Nabelek dating back to 1991. For those of you who are not familiar with this test, here is a quick review of how it works: The test usually is conducted bilaterally in the sound field, not under earphones. You first determine the patient's most comfortable listening level (MCL) for continuous discourse. The standard material is a travelogue about Arizona. It's a loudness task, not a speech recognition task, so the actual speech material doesn't matter too much.

from #Audiology via ola Kala on Inoreader http://ift.tt/1OIhEzj
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/20pqPuQ
via IFTTT

Hearing Aid Directionality with Binaural Processing

The fact that two ears are better than one is well-established. The human auditory system integrates information from both ears providing benefits in terms of loudness, localization, sound quality, noise suppression, speech clarity and listening in noise. The ability to selectively attend to particular sounds, like a single voice among many talkers, is one of the most amazing and significant benefits of binaural hearing.

from #Audiology via ola Kala on Inoreader http://ift.tt/1OIhsAd
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TEoBHt
via IFTTT

Hearing Aid Directionality with Binaural Processing

The fact that two ears are better than one is well-established. The human auditory system integrates information from both ears providing benefits in terms of loudness, localization, sound quality, noise suppression, speech clarity and listening in noise. The ability to selectively attend to particular sounds, like a single voice among many talkers, is one of the most amazing and significant benefits of binaural hearing.

from #Audiology via xlomafota13 on Inoreader http://ift.tt/1OIhsAd
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/20pqt7z
via IFTTT

Hearing Aid Selection and Fitting Tips Gleaned from Recent Research

The first thing I would like to talk about is the Acceptable Noise Level (ANL) test that was developed at the University of Tennessee, based on the research of Anna Nabelek dating back to 1991. For those of you who are not familiar with this test, here is a quick review of how it works: The test usually is conducted bilaterally in the sound field, not under earphones. You first determine the patient's most comfortable listening level (MCL) for continuous discourse. The standard material is a travelogue about Arizona. It's a loudness task, not a speech recognition task, so the actual speech material doesn't matter too much.

from #Audiology via xlomafota13 on Inoreader http://ift.tt/1OIhEzj
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TEowDw
via IFTTT

Hearing Aid Directionality with Binaural Processing

The fact that two ears are better than one is well-established. The human auditory system integrates information from both ears providing benefits in terms of loudness, localization, sound quality, noise suppression, speech clarity and listening in noise. The ability to selectively attend to particular sounds, like a single voice among many talkers, is one of the most amazing and significant benefits of binaural hearing.

from #Audiology via ola Kala on Inoreader http://ift.tt/1OIhsAd
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/20pqvMv
via IFTTT

Pangolin armor: overlapping, structure, and mechanical properties of the keratinous scales

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Bin Wang, Wen Yang, Vincent R. Sherman, Marc A. Meyers
The pangolin has a flexible dermal armor consisting of overlapping keratinous scales. Although they show potential for bioinspired flexible armor, the design principles of pangolin armor are barely known. Here we report on the overlap organization, hierarchical structure (from the nano to the mesolevel), and mechanical response of scales from ground (Chinese) and arboreal (African tree) pangolins. Both scales exhibit the same overlap organization, with each scale at the center of neighboring scales arranged in a hexagonal pattern. The scales have a cuticle of several layers of loosely attached flattened keratinized cells, while the interior structure exhibits three regions distinguished by the geometry and orientations of the keratinized cells, which form densely packed lamellae; each one corresponds to one layer of cells. Unlike most other keratinous materials, the scales show a crossed-lamellar structure (∼5 μm) and crossed fibers (∼50 μm). A nano-scale suture structure, observed for the first time, outlines cell membranes and leads to an interlocking interface between lamellae, thus enhancing the bonding and shear resistance. The tensile response of the scales shows an elastic limit followed by a short plateau prior to failure, with Young's modulus ∼1 GPa and tensile strength 60∼100 MPa. The mechanical response is transversely isotropic, the result of the cross lamellar structure. The strain rate sensitivity in the range of 10-5 to 10-1 s-1 region is found to be equal to 0.07-0.08, typical of other keratins and polymers. The mechanical response is highly dependent on the degree of hydration, a characteristic of keratins.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDWoEZ
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1qE0PzE
via IFTTT

The Early Days of PEG and PEGylation (1970s-1990s)

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Allan S. Hoffman
The idea to conjugate PEG [poly(ethylene glycol)] to a protein, i.e., to "PEGylate" a protein, was first proposed by Prof. Frank Davis (Rutgers Univ.) in the late 1960s. He wanted to make the new recombinant proteins less immunogenic in our bodies, and thereby enhance their circulation and activity lifetimes. He thought that if he could conjugate a hydrophilic polymer to the "new" protein, it might not be recognized by the immune system as a foreign molecule. This article is a contribution to the Zwitterionic Special Issue as a personal commentary tracing the story of PEGylation from its beginning with Dr. Davis through a currentday post-script.Statement of significantThe author knows (or knew) personally most of the early workers in the fields of PEG, PEGylation and non-fouling surfaces, and he has also been personally active in the field since its early days.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDWa0F
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1qE0JrH
via IFTTT

Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Clara González-Chomón, Maite Silva, Angel Concheiro, Carmen Alvarez-Lorenzo
Combination of the ability of contact lenses (CLs) to act as a physical barrier against airborne antigen and to serve as a sustained depot of antihistaminic drugs may improve the efficiency of treatments of some ocular allergic diseases. The aim of this work was to develop CLs that exhibit affinity to olopatadine by mimicking the composition of the natural H1-receptor for which olopatadine behaves as a selective antagonist. Functional monomers that match the chemical groups of the receptor and application of the molecular imprinting technology led to hydrogels able to load high amounts of olopatadine and to sustain the release once in contact with lachrymal fluid. Optimized hydrogels prepared with acrylic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid and benzylmethacrylate as functional monomers provided in few hours olopatadine concentrations similar to those of commercially available eye drops but the levels could be sustained for a whole day, demonstrating their efficacy. Olopatadine-loaded CLs successfully passed the HET-CAM test of ocular irritancy and showed good compatibility with mast cells. They were able to inhibit the release of histamine and TNF-α from sensitized mast cells, proving their potential application in preventing and treating allergic conjunctivitis.Statement of significanceContact lenses (CLs) with affinity for antiallergic drugs may constitute an advantageous alternative to eye drops in management of ocular allergies for both contact lens wearers and patients who eventually use neutral CLs as therapeutic platforms. The present work represents a step forward in the state of the art of drug-CL combo products by (i) mimicking the composition of the human receptor of the drug, (ii) exploring combinations of functional monomers that include a monomer (2-acrylamido-2-methyl-1-propanesulfonic acid; AMPSA) with a strong acid group (pKa <4) able to enhance the interaction of the network with olopatadine in the saline environment of the lachrymal fluid, and (ii) analysing in detail the antihistamic effects provided by olopatadine released from the CLs on sensitized mast cells.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDVZlZ
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1WJWs3U
via IFTTT

Development of a new family of monolithic calcium (pyro)phosphate glasses by soft chemistry

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Jérémy Soulié, Pierre Gras, Olivier Marsan, Danielle Laurencin, Christian Rey, Christèle Combes
The development of bioactive phosphate-based glasses is essential in biomaterials science, and especially for bone substitution applications. In this context, the preparation of amorphous calcium-phosphorus hydroxide/oxide monoliths at low temperature is a key challenge for being able to develop novel hybrid materials for these applications. We herein report for the first time the synthesis and physical chemical characterisation of a novel family of pyrophosphate-based glasses (with the formula: {[(Ca2+)1-x(H+/K+)2x]2[(P2O74-)1-y(PO43-)4y/3]} n(H2O)), which were prepared by soft chemistry using low temperatures (T < 70°C) and water as a solvent. The effect of the initial Ca/Pyrophosphate ratio on the structure and morphology of these pyrophosphate glasses was investigated in detail. Depending on this ratio, a glass (mixed calcium pyro- and orthophosphate) or a glass-ceramic (Ca10K4(P2O7)6·9H2O crystals embedded in the amorphous phase) was obtained. The proportion of the crystalline phase increased with an increase in the Ca/Pyrophosphate ratio in the batch solution. As expected for a glass, the formation of the glassy material was demonstrated not to be thermodynamically but rather kinetically driven, and the washing step was found to be crucial to prevent crystallisation. The stability of the amorphous phase was discussed considering the structural degrees of freedom of pyrophosphate entities, ionic strength of the initial solution and the inhibitory effect of orthophosphate ions. Overall, this new strategy of preparation of monolithic calcium-(pyro)phosphate based glasses using soft chemistry in water is highly promising in view of preparing new functional organic-inorganic hybrids for bone substitution applications.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDWts8
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1WJWicM
via IFTTT

Fatigue behaviors of HP-Mg, Mg-Ca and Mg-Zn-Ca biodegradable metals in air and simulated body fluid

Publication date: Available online 21 May 2016
Source:Acta Biomaterialia
Author(s): Dong Bian, Weirui Zhou, Yang Liu, Nan Li, Yufeng Zheng, Zhili Sun
The dynamic loading in human body, along with the corrosive body fluid, presents a great challenge for the practical use of biodegradable magnesium implants. In this study, a high purity magnesium (99.99 wt.%) and two typical promising biodegradable magnesium alloys (binary Mg-1Ca and ternary Mg-2Zn-0.2Ca) were chosen as the experimental materials. Their dynamic mechanical performances were comparatively evaluated by carrying out fatigue tests in air and in simulated body fluid (SBF). The fatigue strengths of HP-Mg, Mg-1Ca and Mg-2Zn-0.2Ca were all around 90 MPa in air, however, they decreased to 52 MPa, 70 MPa and 68 MPa in SBF at 4×106 cycles, respectively. The fatigue cracks initiated from the microstructural defects when tested in air, but nucleated from surface corrosion pits when tested in SBF. Cyclic loading significantly increased the corrosion rates of all the experimental materials compared to that in static SBF. Moreover, based on our findings, the fatigue failure processes and interactions between material, corrosion and cyclic loading were systematically discussed.Statement of SignificanceFatigue strength and life are vital parameters to the design of metallic implant devices. For the corrosion fatigue of biomedical magnesium alloys, we reported the corrosion fatigue behavior of AZ91D and WE43 in SBF (Acta Biomaterialia, 6 (2010) 4605-4613), and till now there is no other reports to our knowledge. We spent 3 years to finish the fatigue testing and get S-N curves for three more magnesium biomaterials, and our significant finding is that the fatigue strengths of HP-Mg, Mg-1Ca and Mg-2Zn-0.2Ca are all around 90 MPa in air but 52 MPa, 70 MPa and 68 MPa in SBF at 4×106 cycles, which will provide the first-hand data for the future magnesium implants design.

Graphical abstract

image


from #Dental via xlomafota13 on Inoreader http://ift.tt/1qDW6xQ
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1qE0NaY
via IFTTT

Bleak allergy

Dear Editor,
The prevalence of fish allergy in the general population is 0.1%–3%.1 Bleak (Alburnus alburnus) is a river fish belonging to the Cyprinidae family ( Fig. 1).2 Different fish-related panallergens have been described. 13 and 4 We report the first case of allergy to bleak where a panallergen was the sole trigger.
Bleak (Alburnus alburnus) of 15 cm in length.
Fig. 1. 
Bleak (Alburnus alburnus) of 15 cm in length.
We present the case of a 69-year-old non-atopic woman who suffered from edema of the tongue, uvular edema, generalized pruritic erythema and rapidly progressive dyspnea immediately after eating one piece of fried bleak. No other family member who ate the same fish had similar symptoms. One month before, she presented generalized urticaria after eating this fish previously well tolerated. Currently, she completely avoids fish and seafood. An allergy work-up was performed.
Skin-prick-prick (SPP) tests were positive (papule ≥3 mm than negative control) to river (bleak, pike, barbel, carp, trout) and sea (hake, cod, sardine, salmon) fish; and negative to anchovy, white tuna and red tuna. Skin-prick-tests (SPT) with negative (50% glycerinated saline) and positive (histamine, 10 mg/mL) controls were performed (BIAL-Arístegui, Bilbao, Spain). SPT was positive to extracts of bleak (body and head), carp, barbel, pike, hake, cod, sardine and salmon; and negative to sole, anchovy, tuna, clam, oyster, squid, prawn and Anisakis simplex. Protein extracts from pike, barbel and carp (bodies), and bleak (body and head) were prepared by homogenization in phosphate-buffered-saline, dialyzation and lyophilization.
Serum total IgE, specific IgE and baseline tryptase levels were measured by ImmunoCAP™ (ThermoFisher, Massachusetts, USA). Serum specific IgE levels against bleak body and head were measured with the enzyme allergosorbent technique (Specific IgE EIA kit, HYTEC, HYCOR Biomedical Ltd., USA). Two parvalbumin-dependent anaphylaxis patients served as positive blotting-assay controls (patient #1: serum specific IgE against Gad c 1 of 1.08 kUA/L; patient #2 of 38.40 kUA/L) (negative <0.35 kUA/L). Serum total IgE was 153 UI/mL (normal <100). Specific IgE against A. simplex was negative (<0.10 kUA/L) and positive to cod (1.34 kUA/L) and salmon (0.70 kUA/L). In contrast, specific IgE against different fish (trout, tilapia, grayling, bullhead, zander, sardine, anchovy, hake, tuna) and seafood (shrimp, mussel, squid) were negative (between 0.14 and 0.04 kUA/L) as well as against the parvalbumins Gad c 1 (0.06 kUA/L) and Cyp c 1 (0.12 kUA/L) and tropomyosinDer p 10 (<0.10 kUA/L). Serum baseline tryptase levels were of 3.6 and 4.1 μg/L (normal <11.4). Specific IgE levels to body and head bleak extracts were <0.35 kUA/L but higher than the value obtained with a control serum (pool of sera from non-atopic subjects), so both values were between 0.35 and 0 kUA/L.
Therefore, to ascertain whether bleak was the real cause of this anaphylactic reaction, bleak extracts (body and head) were studied by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions (2-mercaptoethanol),5 transferred onto polyvinylidene difluoride membrane filters (Millipore Corp., Bedford, Massachusetts, USA), and incubated with patient serum. Two IgE-binding bands of 55 kDa and less than 14 kDa were revealed in both bleak extracts (results not shown). An IgE-Immunoblotting assay after tricine-SDS-PAGE analysis with bleak body extract was performed as previously described.6 The membrane was incubated with patient serum and with a rabbit anti-serum against sardine parvalbumin. The same IgE-binding band profile was revealed with both sera. This result led us to suppose that all the IgE-binding bands detected were different aggregation states of the bleak parvalbumin, and the 11 kDa-IgE-binding band was the monomeric state of this protein (Fig. 2-I). Furthermore, the extracts of various river fish (pike, carp and barbel) were studied by the SDS-PAGE Immunoblotting method as described by Laemnli using patient serum and the sera from the two parvalbumin-allergic patients.5 The IgE-binding band profile was the same with the three sera, and the parvalbumin protein appeared as a protein with a molecular mass smaller than 14 kDa. The other higher bands observed are the different aggregation states of the parvalbumin as was detected by tricine-SDS-PAGE IgE-Immunoblotting (Fig. 2-I). SDS-PAGE Immunoblotting inhibition assays using extracts from pike, carp and barbel body (solid phases) showed that both bleak extracts (body and head) as well as carp, pike and barbel bodies were able to produce a total IgE binding inhibition on proteins from pike, carp and barbel extracts (Fig. 2-II). Finally, in order to confirm a clinical monosensitivity to bleak and/or to offer a safe alternative fish diet, we performed an oral food challenge (OFC) with canned tuna (negative specific IgE, SPT and SPP), raw red tuna (negative SPP) and anchovy (negative specific IgE, SPT and SPP) in a very cautious way as previously described.7 and 8 Our patient tolerated canned tuna and raw red tuna (both fish with no detected parvalbumin/g of fish),1but not anchovy. Subsequently, no OFC with other fish was performed. She also tolerated squid, shrimp and mussel.
I) SDS-PAGE Immunoblotting. A) Extract from raw bleak body; B) Extract from raw ...
Fig. 2. 
I) SDS-PAGE Immunoblotting. A) Extract from raw bleak body; B) Extract from raw barbel body. Lane P1, patient's serum; lane C, control serum (pool of sera from non-atopic subjects); lane S, rabbit anti-serum against sardine parvalbumin; lane C1, unimmunized rabbit serum; lane M, molecular mass marker; lane P2and P3, sera from control parvalbumin-allergic patients. II) SDS-PAGE Immunoblotting-inhibition showing the obtained results with barbel body extract as solid phase; the results were similar with pike and carp as solid phase. Solid phase: Extract from raw barbel body. Lane C, control serum (pool of sera from non-atopic subjects); lanes 1–6, patient's serum pre-incubated with raw barbel body extract (1), raw bleak body extract (2), raw bleak head extract (3), raw pike body extract (4), raw carp body extract (5), and lamb extract (6); lane M, molecular mass marker.
Spain is the country with the third highest fish consumption after Japan and Portugal.9Currently, part of the Spanish population consumes river non-marketed fish perhaps with the intention of avoiding Anisakis-parasited fish, but overlooking the risk of coming into contact with other allergenic fish proteins. Fish parvalbumins are proteins of 9–11 kDa which show a high degree of IgE cross-reactivity between them, including parvalbumin from river fish. 1,3 and 4 We highlight the negative specific IgE values detected in our patient's serum against the commercially available parvalbumins, Gad c 1 and Cyp c 1 (parvalbumin from a river fish) (ImmunoCAP system). Thus, our patient could have been diagnosed with an allergy exclusive to bleak and a life-threatening episode after eating other fish could have occurred.
In conclusion, as far as we know, this is the first published case of allergy to bleak. The parvalbumin proved to be the allergen even though a negative specific IgE value to parvalbumins was detected by means of conventional analyses, which are used for diagnosing parvalbumin-induced fish allergies. In this case, the clinical significance of the allergenic cross-reactivity between bleak parvalbumin and parvalbumin from river and sea fish was demonstrated by serologic tests and OFC.

Conflicts of interest

BB is an employee of BIAL-Arístegui. The rest of the authors have no conflict of interest.

Acknowledgments

This work was partially supported by a grant from Comunidad de Madrid MITIC-CM(S2010/BMD-2502). The work did not receive any grant, honorary, fees from BIAL-Arístegui, the employer of the author BB.

References

    • 2
    • U.S. Fish and Wildlife Service. Beak (Alburnus alburnus), Ecological Risk Screening Summary. Web Version of July 21, 2014. Available at http://ift.tt/27PYZgW.
    • 3
    • A. Kuehn, I. Swoboda, K. Arumugam, C. Hilger, F. Hentges
    • Fish allergens at a glance: variable allergenicity of parvalbumins, the major fish allergens
    • Front Immunol, 5 (2014), p. 179
    • 7
    • N. Yanagida, Y. Okada, S. Sato, M. Ebisawa
    • New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapies
    • Allergol Int, 65 (2016), pp. 135–140
    •  |   | 
    • 8
    • S. Vázquez-Cortés, B. Nuñez-Acevedo, L. Jimeno-Nogales, A. Ledesma, M. Fernández-Rivas
    • Selective allergy to the Salmonidae fish family: a selective parvalbumin epitope?
    • Ann Allergy Asthma Immunol, 109 (2012), pp. 362–363
    •  |   | 
    • 9
    • M. Perez-Gordo, J. Cuesta-Herranz, A.S. Maroto, B. Cases, M.D. Ibáñez, F. Vivanco, et al.
    • Identification of sole parvalbumin as a major allergen: study of cross-reactivity between parvalbumins in a Spanish fish-allergic population
    • Clin Exp Allergy, 41 (2011), pp. 750–758
    •  |   | 
Peer review under responsibility of Japanese Society of Allergology.
Corresponding author. Servicio de Enfermedades del Sistema Inmune–Alergia, Hospital Universitario Príncipe de Asturias, Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá, Carretera Madrid-Barcelona Km 33.600, Alcalá de Henares, Madrid, Spain.
Source:Allergology International
Author(s): José Barbarroja-Escudero, María-José Sánchez-González, Mercedes Rodríguez-Rodríguez, Darío Antolín-Amérigo, Borja Bartolomé, Melchor Alvarez-Mon


from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/27PZ83O
via IFTTT

Αρχειοθήκη ιστολογίου